MiMedx Group, Inc. (MDXG) Cash Flow Statement
MiMedx Group, Inc. (MDXG) generated $46.1M of operating cash flow over the twelve months to 2026-06-30, spent $1.6M on capital expenditure and had free cash flow of $44.5M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MDXGMiMedx Group, Inc.Follow MDXG — free
—
Price chart with a free account
- Market cap
- 569.9M
- P/E TTM
- 97.8
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2011 Dec 11 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -6.7 | 35.8 | -39.4 | -30.3 | -2.0 | -17.9 | 26.8 | 66.2 | 74.0 | 46.1 | |
| Capital expenditure | 0.5 | 9.4 | 1.8 | 4.2 | 3.2 | 1.5 | 2.0 | 1.7 | 1.0 | -1.6 | |
| Free cash flow | -7.2 | 26.4 | -41.2 | -34.5 | -5.2 | -19.4 | 24.8 | 64.5 | 73.0 | 44.5 | |
| Share repurchases | — | 7.6 | — | 0.9 | 0.0 | 0.0 | 9.5 | 0.0 | 0.0 | — | |
| Stock-based compensation | 1.7 | 14.8 | 12.1 | 15.4 | 14.2 | 11.3 | 17.0 | 16.9 | 16.4 | — |
USD millions · SEC XBRL
MiMedx Group, Inc. — questions
- What is MiMedx Group, Inc.'s operating cash flow?
- $46.1M over the twelve months to 2026-06-30.
- How much does MiMedx Group, Inc. spend on capital expenditure?
- $1.6M over the twelve months to 2026-06-30.
- What is MiMedx Group, Inc.'s free cash flow?
- $44.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from MiMedx Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.